The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121874296 12187429 6 F 20130802 20160809 20160317 20160812 EXP PHHY2013CA085616 NOVARTIS 53.45 YR F Y 0.00000 20160812 CN COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121874296 12187429 1 SS XOLAIR OMALIZUMAB 1 Subcutaneous 300 MG, EVERY 2 WEEKS U 0 300 MG VIAL QOW
121874296 12187429 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
121874296 12187429 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
121874296 12187429 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
121874296 12187429 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
121874296 12187429 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0062 0 VIAL
121874296 12187429 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0065E 0 VIAL
121874296 12187429 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0066B 0 VIAL
121874296 12187429 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
121874296 12187429 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0003C 0 VIAL
121874296 12187429 11 PS SEEBRI BREEZHALER GLYCOPYRROLATE 1 Respiratory (inhalation) U 207923
121874296 12187429 12 C ZENHALE FORMOTEROL FUMARATEMOMETASONE FUROATE 1 Unknown U 0
121874296 12187429 13 C VENTOLIN ALBUTEROL SULFATE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121874296 12187429 1 Asthma
121874296 12187429 11 Product used for unknown indication
121874296 12187429 12 Product used for unknown indication
121874296 12187429 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
121874296 12187429 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
121874296 12187429 Arthralgia
121874296 12187429 Blood pressure increased
121874296 12187429 Body temperature decreased
121874296 12187429 Breath sounds abnormal
121874296 12187429 Carpal tunnel syndrome
121874296 12187429 Chest pain
121874296 12187429 Cough
121874296 12187429 Discomfort
121874296 12187429 Dizziness
121874296 12187429 Dysphonia
121874296 12187429 Dyspnoea
121874296 12187429 Erythema
121874296 12187429 Feeling hot
121874296 12187429 Headache
121874296 12187429 Hypoaesthesia
121874296 12187429 Jaw disorder
121874296 12187429 Lower respiratory tract infection
121874296 12187429 Malaise
121874296 12187429 Rales
121874296 12187429 Rash
121874296 12187429 Sinusitis
121874296 12187429 Skin reaction
121874296 12187429 Sleep disorder
121874296 12187429 Stress
121874296 12187429 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121874296 12187429 1 20130510 0
121874296 12187429 2 20131030 0
121874296 12187429 3 20131127 0
121874296 12187429 4 20140206 0
121874296 12187429 5 20140807 0
121874296 12187429 6 20160302 0
121874296 12187429 7 20160331 0
121874296 12187429 8 20160512 0
121874296 12187429 9 20160531 0
121874296 12187429 10 20160721 0